Skip to main content
. 2023 Jul 14;14:1148595. doi: 10.3389/fimmu.2023.1148595

Figure 6.

Figure 6

Gene expression profiles of metallothioneins. Expression levels of the MTs in patients with persistent olfactory symptoms (Group 1), with full recovery of olfactory perception (Group 2) or who never experienced olfactory symptoms (Group 3) was measured by RNA-Seq (A) and qRT-PCR (B). Data were compared by t-test *p-value ≤ 0.05, **p-value ≤ 0.01.